Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm.

Tsur N, Kogan Y, Avizov-Khodak E, Vaeth D, Vogler N, Utikal J, Lotem M, Agur Z

DOI: 10.1186/s12967-019-2081-2
Published: 2019 Oct 7
Container: Journal of translational medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12967-019-2081-2,
  title = {Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm.},
  author = {Tsur N and Kogan Y and Avizov-Khodak E and Vaeth D and Vogler N and Utikal J and Lotem M and Agur Z},
  year = {2019},
  journal = {Journal of translational medicine},
  doi = {10.1186/s12967-019-2081-2},
  url = {https://doi.org/10.1186/s12967-019-2081-2}
}

RIS

TY  - JOUR
TI  - Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm.
AU  - Tsur N
AU  - Kogan Y
AU  - Avizov-Khodak E
AU  - Vaeth D
AU  - Vogler N
AU  - Utikal J
AU  - Lotem M
AU  - Agur Z
PY  - 2019
JO  - Journal of translational medicine
DO  - 10.1186/s12967-019-2081-2
UR  - https://doi.org/10.1186/s12967-019-2081-2
ER  -

APA

N, T., Y, K., E, A., D, V., N, V., J, U., M, L., & Z, A. (2019). Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm.. Journal of translational medicine. https://doi.org/10.1186/s12967-019-2081-2

Source records

pubmed · retrieved 2026-09-25T14:19:23.534Z